Facioscapulohumeral Muscular Dystrophy Clinical Trial
Official title:
Unraveling Metabolic Involvement in Facioscapulohumeral Dystrophy Through Metabolomics
The pathogenesis of facioscapulohumeral dystrophy (FSHD), one of the most prevalent types of inherited muscle disease, is unknown. The reasons underlying its significant clinical heterogeneity, incomplete penetrance, and sex specific differences in the age of onset, are not currently understood. While metabolic changes associated with this disease have so far deserved little attention, recent studies have pinpointed significant metabolic dysregulation as an emerging driving mechanism in the pathophysiology of this untreatable disease. To test this hypothesis, we will perform a deep metabolic phenotyping in a large cohort of highly clinically characterized FSHD patients at different stage of disease and age/sex-matched controls by state-of-art plasma metabolomic and mitochondrial biomarker profiling. These data will allow attributing specific metabolomic signatures to different stages of the disease in each sex. Metabolic pathway analysis will allow gaining insights into the type of metabolic dysregulation associated with the disease pathogenesis, leading to the identification of targeted metabolic/nutritional interventions and biomarker discovery.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT00082108 -
Myotonic Dystrophy and Facioscapulohumeral Muscular Dystrophy Registry
|
||
| Completed |
NCT02579239 -
Evaluate Safety and Biological Activity of ATYR1940 in Participants With Limb Girdle Muscular Dystrophy 2B (LGMD2B) and Facioscapulohumeral Muscular Dystrophy (FSHD)
|
Phase 1/Phase 2 | |
| Terminated |
NCT02927080 -
Study of ACE-083 in Patients With Facioscapulohumeral Muscular Dystrophy (FSHD)
|
Phase 2 | |
| Completed |
NCT02625662 -
Facioscapulohumeral Dystrophy in Children
|
||
| Recruiting |
NCT04001582 -
The United Kingdom Facioscapulohumeral Muscular Dystrophy Patient Registry
|
||
| Recruiting |
NCT06425445 -
Quantitative Assessment of Orofacial Muscle Function in FSHD
|
N/A | |
| Terminated |
NCT03943290 -
Extension Study to Evaluate the Long-Term Effects of ACE-083 in Patients With Facioscapulohumeral Muscular Dystrophy (FSHD) and Charcot-Marie Tooth (CMT) Disease Types 1 and X (CMT1 and CMTX)
|
Phase 2 | |
| Completed |
NCT01596803 -
Effects Antioxidants Supplementation on Muscular Function Patients Facioscapulohumeral Dystrophy (FSHD)
|
N/A | |
| Active, not recruiting |
NCT03458832 -
Clinical Trial Readiness to Solve Barriers to Drug Development in FSHD
|
||
| Completed |
NCT02766985 -
Rasch-analysis of Clinical Severity in FSHD
|
||
| Active, not recruiting |
NCT01671865 -
Magnetic Resonance Imaging and Spectroscopy Biomarkers for Facioscapulohumeral Muscular Dystrophy
|
||
| Completed |
NCT02413190 -
Bone Health in Facioscapulohumeral Muscular Dystrophy
|
||
| Completed |
NCT01931644 -
At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions
|
||
| Completed |
NCT01437345 -
A Multicenter Collaborative Study on the Clinical Features, Expression Profiling, and Quality of Life of Infantile Onset FSHD
|
N/A | |
| Completed |
NCT02836418 -
Study to Evaluate the Long-Term Safety, Tolerability, and Biological Activity of ATYR1940 in Participants With Limb Girdle and Facioscapulohumeral Muscular Dystrophy (FSHD)
|
Phase 1/Phase 2 | |
| Completed |
NCT00821548 -
Electrostimulation of Shoulder Girdle and Quadriceps Muscles in Facioscapulohumeral Muscular Dystrophy Patients
|
N/A | |
| Completed |
NCT05178706 -
Effectiveness of Upper Extremity Rehabilitation in pwFSHD (Patient With Facioscapulohumeral Dystrophia)
|
||
| Completed |
NCT00104078 -
Study Evaluating MYO-029 in Adult Muscular Dystrophy
|
Phase 1/Phase 2 | |
| Recruiting |
NCT05019625 -
Biomarker Development for Muscular Dystrophies
|
||
| Completed |
NCT03123913 -
Study of Testosterone and rHGH in FSHD
|
Phase 1 |